(NASDAQ: CLOV) Clover Health Investments's forecast annual revenue growth rate of 17.85% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 3.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.98%.
Clover Health Investments's revenue in 2026 is $2,476,713,000.On average, 6 Wall Street analysts forecast CLOV's revenue for 2026 to be $1,600,373,820,419, with the lowest CLOV revenue forecast at $1,529,730,037,440, and the highest CLOV revenue forecast at $1,653,489,446,719. On average, 6 Wall Street analysts forecast CLOV's revenue for 2027 to be $1,914,818,328,115, with the lowest CLOV revenue forecast at $1,775,124,230,946, and the highest CLOV revenue forecast at $2,012,019,924,244.
In 2028, CLOV is forecast to generate $2,135,248,177,260 in revenue, with the lowest revenue forecast at $2,012,551,080,507 and the highest revenue forecast at $2,236,167,867,230.